Q4 2024 Earnings Call Transcript February 4, 2025 Merck & Co., Inc. misses on earnings expectations. Reported EPS is $1.72 ...

Welcome to the Merck & Company Q4 sales and earnings conference call. [Operator instructions] This call is being recorded.

Given Sobi's cash flow generation from its hemophilia business and mature product Synagis, the firm ended 2024 with a net debt/EBITDA ratio of 1.6 times. We expect the firm can support this level of ...

The US president's tariffs are already causing turmoil on the ASX as investors prepare for a global trade war, and the Greens ...

The General Pharmaceutical Council (GPhC), which regulates pharmacies, said it was responding to concerns relating to the unsafe prescribing and supply of medicines ... said the regulatory agency.

The findings show that MS may affect a person’s… The U.K.’s Medicines ... that may benefit people with multiple sclerosis (MS) and other diseases. Launched in 2015 by the European Commission ...

Adaptive pathways have also been proposed to accelerate the introduction of innovative medicines in Europe (53, 54). However, there are considerable concerns among European payers in this regard, and ...

Up to 20,000 babies may have been affected by exposure to valproate since it was introduced. Some, like the government’s patient safety commissioner, Dr Henrietta Hughes, have branded this “a scandal ...

Deferred Income Tax 0.00 0.00 0.00 0.00 ...

Studies show that excessive consumption of processed meats and red meat may increase the risk of colorectal and other cancers Skin cancer is one of the most common forms of cancer, but it’s also ...

Christopher Boerner; Chairman of the Board, Chief Executive Officer, Chief Operating Officer; Bristol-Myers Squibb Co David Elkins; Executive Vice President, Chief Financial Officer, Member of the ...

Amgen (NASDAQ:AMGN) today announced financial results for the fourth quarter and full year of 2024 versus comparable ...